Tirzepatide price increase

1 paper2 findings

1 lab

Humans1

Associations

2

Tirzepatide-to-semaglutide switching

upin humans1

1 study

Tirzepatide price increase is associated with tirzepatide-to-semaglutide switching in humans (+9.26 percentage points (95% CI 7.09–11.42); subsequently attenuated).
“Tirzepatide-to-semaglutide switching increased by 9.26 percentage points (95% CI: 7.09-11.42) and subsequently attenuated.”
HumansSelf-paying UK adults with overweight or obesitySeptember 2025
Real-World Treatment Patterns and Weight Outcomes Before and After a Tirzepatide Price Increase in Over One Million Self-Paying UK Adults With Overweight or Obesity
Diabetes, obesity & metabolism14 Oct 2026

Semaglutide initiation

upin humans1

1 study

Tirzepatide price increase is associated with semaglutide initiation in humans (+31.15 percentage points (95% CI 26.07–36.24)).
“In September 2025, semaglutide initiation increased by 31.15 percentage points (95% CI: 26.07-36.24) relative to the projected pre-interruption trend.”
HumansRelative to the projected pre-interruption trend among self-paying UK adults with overweight or obesitySeptember 2025n = 1,033,522
Real-World Treatment Patterns and Weight Outcomes Before and After a Tirzepatide Price Increase in Over One Million Self-Paying UK Adults With Overweight or Obesity
Diabetes, obesity & metabolism14 Oct 2026

Latest

1 in 12 months

Diabetes, Obesity & MetabolismYesterday

Real-World Treatment Patterns and Weight Outcomes Before and After a Tirzepatide Price Increase in Over One Million Self-Paying UK Adults With Overweight or Obesity

Cohort study of 1,033,522 peopleTirzepatide